NCT01759303 Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung Status TERMINATED Phase PHASE2
NCT01758666 A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy Status UNKNOWN Phase NA
NCT01674101 Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy Status COMPLETED Phase NA
NCT01669369 Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma Status UNKNOWN Phase PHASE4
NCT01661400 Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors Status COMPLETED Phase PHASE1
NCT01518413 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01492569 Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting Status WITHDRAWN Phase NA
NCT01491594 Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia Status TERMINATED Phase PHASE1
NCT01459484 ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma Status COMPLETED Phase PHASE2
NCT01336803 Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI Status COMPLETED Phase PHASE2
NCT01258634 A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response Status TERMINATED Phase PHASE1
NCT01242072 Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies Status UNKNOWN Phase PHASE1
NCT01236586 RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia Status WITHDRAWN Phase PHASE1
NCT01194284 Surveillance Study of Patients With Newly Diagnosed Osteosarcoma Status TERMINATED Phase N/A
NCT01176981 Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma Status COMPLETED Phase PHASE3
NCT01130623 A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors Status WITHDRAWN Phase PHASE1
NCT01005043 Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma Status COMPLETED Phase PHASE1/PHASE2